- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Tools
Calendars
Short Interest
ImmunityBio (NASDAQ:IBRX), Quotes and News Summary
ImmunityBio (NASDAQ: IBRX)
Day High/Low3.83 - 4.19
52 Week High/Low2.6 - 15.65
Open / Close4.16 / 3.91
Float / Outstanding81.2M / 398M
Vol / Avg.- / 2M
Mkt Cap1.6B
P/E-
50d Avg. Price3.75
Div / Yield-
Payout Ratio-
EPS-0.26
Total Float81.2M
Benzinga - Jun 7, 2022, 12:08PM
Benzinga - Jun 7, 2022, 7:27AM
Benzinga - Jun 6, 2022, 9:01AM
Benzinga - May 23, 2022, 8:38AM
Benzinga - Apr 25, 2022, 9:06AM
Benzinga - Apr 4, 2022, 7:51AM
Benzinga - Apr 1, 2022, 4:15PM
Benzinga - Feb 15, 2022, 12:48PM
Benzinga - Feb 15, 2022, 12:46PM
Benzinga - Feb 14, 2022, 5:17PM
Benzinga - Jan 25, 2022, 6:14AM
Benzinga - Jan 20, 2022, 7:55AM
Benzinga - Jan 19, 2022, 9:27AM
Benzinga - Jan 18, 2022, 6:04PM
Benzinga - Jan 12, 2022, 8:32AM
Benzinga - Jan 3, 2022, 2:43PM
Benzinga - Jan 3, 2022, 12:50PM
Benzinga - Jan 3, 2022, 8:01AM
Benzinga - Dec 28, 2021, 6:11AM
load more
Sector: Health Care.Industry: Biotechnology
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate (natural killer cell and macrophage) and adaptive (T cell) immune systems to create long-term immunological memory.
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-11 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.260 | ||||||
| REV | 14.000K |
ImmunityBio Questions & Answers
Q
How do I buy ImmunityBio (IBRX) stock?
A
You can purchase shares of ImmunityBio (NASDAQ: IBRX) through any online brokerage.
Q
Who are ImmunityBio's (IBRX) competitors?
A
Other companies in ImmunityBio’s space includes: Twist Bioscience (NASDAQ:TWST), Valneva (NASDAQ:VALN), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE) and Xencor (NASDAQ:XNCR).
Q
What is the target price for ImmunityBio (IBRX) stock?
A
There is no analysis for ImmunityBio
Q
Current Stock Price for ImmunityBio (IBRX)?
A
The stock price for ImmunityBio (NASDAQ: IBRX) is $3.91 last updated June 27, 2022, 8:00 PM UTC.
Q
Does ImmunityBio (IBRX) pay a dividend?
A
There are no upcoming dividends for ImmunityBio.
Q
When is ImmunityBio (NASDAQ:IBRX) reporting earnings?
A
ImmunityBio’s Q2 earnings are confirmed for Thursday, August 11, 2022.
Q
Is ImmunityBio (IBRX) going to split?
A
There is no upcoming split for ImmunityBio.
Q
What sector and industry does ImmunityBio (IBRX) operate in?
A
ImmunityBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.